Concentration–QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase‐4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation
CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.12405
Full Text
Open PDFAbstract
Available in full text
Date
May 11, 2019
Authors
Publisher
Wiley